Hypertension and vascular alterations in lupus autoimmunity

Systemic lupus erythematosus (SLE), which is estimated to affect 30–50 people out of 100 000, is considered to be one of the most heterogeneous illnesses to treat [1]. This systemic autoimmune disease manifests itself through an array of symptoms that often include fever, skin rash and arthritis and can lead to lupus nephritis and nervous system disease in more severe cases [1]. This diversity amongst disease manifestations creates challenges...